Background: Information regarding clinical signs, assessment, treatment, and outcome in cats with hiatal hernia (HH) is limited.
Conclusions and Clinical Importance: Type I HH is the most common type of HH in cats. A congenital etiology is possible, but many cats with HH were >3 years of age at diagnosis and suffered from comorbidities, including upper airway obstruction. Case selection and the presence of comorbidities likely influenced the outcome. Cats with HH may not be diagnosed until disease is advanced or concurrent illness draws attention to clinical signs. Hiatal hernia (HH) in dogs and cats is defined as protrusion of abdominal contents, most often the cardia and fundus of the stomach, through the esophageal hiatus into the caudal mediastinum. [1] [2] [3] [4] [5] [6] [7] [8] [9] In people, 4 types of HH are described in a classification scheme that also is applied to dogs and cats. [1] [2] [3] [4] [5] [6] [7] [8] [9] Although limited data are available for cats, type I sliding HH is the most common type of HH in dogs, and simple and complicated type II paraesophageal hernias also are described relatively commonly. [1] [2] [3] [4] [5] 7, 8 Hiatal hernia reportedly is often congenital in small animals, and affected dogs commonly display clinical signs before 1 year of age. 1, 3, 5, 7, 9 Concurrent respiratory conditions may predispose to clinical signs, and brachycephalic syndrome, other causes of upper airway obstruction, and lower airway diseases have been reported in dogs with HH. 4, 7, 9 Inspiratory dyspnea causes more subatmospheric intrapleural and intraesophageal pressures that may facilitate stretching of the phrenoesophageal ligament and cranial displacement of the stomach through the esophageal hiatus. 1, 4, 7, [9] [10] [11] Clinical signs in dogs with HH include regurgitation, vomiting, hypersalivation, dysphagia, anorexia, respiratory distress, and weight loss. 1, 5, 9, [12] [13] [14] Recommendations for treatment are debated, and the choice between medical and surgical management often is dictated by clinician preference and the severity of clinical signs. 13, 15 Because information regarding HH in cats is limited to that derived from single case reports or small case series, little is known regarding clinical signs, superiority of any assessment tool or treatment option, and outcome in cats with HH. 2, 8, 10, 12, 14, [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] Our objective was to characterize the clinical presentation of HH in cats, including historical and physical examination findings and results of diagnostic imaging, and medical and surgical outcomes.
| MATERIALS AND METHODS

| Case selection criteria
Medical records of cats treated for HH at 6 tertiary care veterinary teaching hospitals between January 1, 1995, and December 31, 2016, were retrospectively reviewed. Cats were included in the study if gastrointestinal signs were present and HH was diagnosed by survey radiography, contrast esophagography, computed tomography (CT), esophagoscopy, or videofluoroscopic swallowing studies. Cats diagnosed with HH after known trauma were excluded.
| Medical records review
History; signalment; body weight at presentation; results of physical examination and diagnostic imaging; surgical technique, operative findings, and complications; medical treatments; histopathologic diagnoses; survival to discharge and overall survival; necropsy results; and outcome were recorded. Respiratory rate <40 breaths per minute was considered normal and >40 bpm was considered abnormal. Respiratory effort was coded as normal or as abnormal characterized by short, shallow breathing; increased abdominal effort on inspiration; paradoxical abdominal motion; or open-mouth breathing. Outcome was characterized by the occurrence and type of complications after treatment, resolution of clinical signs, and median number of days to death or follow-up. Follow-up was obtained by telephone communication with the client using a standardized questionnaire (see Supporting Information). In the questionnaire, owners were asked to rate the severity of their cats' clinical signs on a scale of 1 to 5, with a score of 1 being mild and 5 being severe. Surgical treatment was defined as an abdominal approach to the esophageal hiatus, reduction of hernia contents, and ≥1 of the following procedures: phrenoplasty (esophageal hiatus plication), esophagopexy, gastropexy, or fundoplication as previously described. [1] [2] [3] [4] [5] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] 26 Medical management was defined as treatment with histamine-2 receptor antagonists (H 2 RAs), proton pump inhibitors (PPIs), gastrointestinal prokinetic drugs (cisapride or metoclopramide), cytoprotective medications (sucralfate), or dietary modification including frequent, small-volume feeding of a fat-restricted diet, feeding from an elevated position, or administering food of a more liquid consistency to enhance gastric emptying. Swallowing studies evaluated all phases of swallowing from oropharyngeal to esophageal to gastroesophageal.
The following were considered abnormal findings: gastric rugae cranial to the diaphragm indicative of HH, esophageal stricture, gastroesophageal reflux (GER), focal or diffuse esophageal dysmotility represented by the absence of peristaltic waves or inappropriate timing of peristaltic waves relative to bolus presentation, barium aspiration, irregular esophageal or gastric mucosa, or esophageal perforation.
| Statistical analysis
Descriptive statistics, related plots, and preliminary statistical analyses were obtained using menu-driven Systat 13.1 (Systat Inc, San Jose, California). Mean, median, standard deviation (SD), and n were calculated for all variables for all cats, and P < .05 was considered significant.
These statistical variables also were calculated for subsets having sur- 
| RESULTS
Thirty-one cats met the inclusion criteria. Seventeen (54.8%) cats were male (15 castrated and 2 sexually intact) and 16 (51.6%) were female (2 spayed and 14 sexually intact). Median age at presentation was Median weight of cats treated medically without surgery was significantly higher than that of cats treated surgically (4.7 kg [range, 2.8-6.8 kg] versus 2.4 kg [range, 0.5-6.9 kg], respectively [P = .005]).
All 31 (100%) cats survived to discharge a median of 2.8 days (range, 0-15 days) after presentation. Postdischarge survival data were available for 20 cats, of which 4 of 20 (20%) cats were treated medically without surgery and 16 of 20 (80%) were treated surgically. Table 1 summarizes median days to death or follow-up in cats treated medically with or without surgery. Median days to death or follow-up for cats treated medically without surgery were 2559 days (range, 1095-4015 days), and median days to death or follow-up for cats treated surgically were 771 days (range, 3-3599 days). Median days to death or follow-up for all cats were 959 days (range, 3-4015 days).
Median duration of clinical signs was 170 days (range, 7-3650 days).
Gastrointestinal signs were present in 30 of 31 (96.8%) cats, and vomiting, weight loss, and anorexia were most common, reported in 13 (43.3%), 9 (30%), and 7 (23.3%) of 30 cats, respectively. Regurgitation was reported in 3 of 30 (10%) cats, and tenesmus was reported in 2 of 30 (6.7%) cats. Hiding and gagging were reported rarely. Type and duration of clinical signs did not differ significantly between cats treated medically with or without surgery.
On physical examination, 9 (29%) cats had evidence of upper or lower airway disease or obstruction. Of these, 3 (33.3%) cats were brachycephalic breeds including Persian (n = 2) and Himalayan (n = 1) breeds. Three ( The most common type of HH diagnosed in this cohort was type I sliding HH; a predominance of type I HH also is observed in people and dogs. 1, 3, 5, 7, 9 Hiatal hernia often is congenital in origin, and over 75% of reported dogs and 67% of previously reported cats with HH were <1 year of age at diagnosis, although fewer than 30 cats with HH were reported in the veterinary literature before our study. 1, 2, 5, 6, 8, 9, 12, [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] Only 8 of 31 (25.8%) cats in our study were <1 year of age, and the majority of cats in our study (20/ Brachycephalic dogs with HH exhibit frequent vomiting, regurgitation, and hypersalivation with esophagitis and diffuse gastric and duodenal inflammation. 3, 32, 33 Brachycephalic syndrome has been implicated as a cause for type I HH in dogs because increased inspiratory effort causes more subatomspheric intraesophageal and intrapleural pressures, stretching of the phrenoesophageal ligament, paradoxical cranial movement of the stomach, and HH. 1, 9, 17, 32, 33 Our findings suggest that diseases causing airway obstruction also may be important in the development of HH in cats. Airway obstruction was diagnosed concurrently with HH in 9 of 31 (29%) cats in our study, including brachycephalic cats and cats with chronic rhinitis. Hiatal hernia has been described previously in a cat associated with chronic rhinitis causing nasopharyngeal stenosis and upper airway obstruction. 9, 17 Further prospective studies are needed to determine the prevalence esophagography was diagnostic for HH in 100% of the cats in our study in which it was performed, as was thoracic CT. 2, 7, 9, 14, 31 Cats with HH may elude diagnosis by any imaging modality, however, because type I herniation is intermittent and varies in severity.
The most common presenting clinical sign was vomiting that occurred in 13 of 31 (41.9%) cats, similar to what is observed in dogs. 1, 5, 9, 12, 13, 30 Gastrointestinal signs are attributable to GER and reflux esophagitis. Given the poorly understood pathophysiology of HH, GER, and reflux esophagitis in cats, careful patient consideration is required when recommending medical or surgical treatment for HH. All cats in our study received ≥1 medications for gastrointestinal clinical signs, and 29 of 31 (95.5%) cats received ≥2 medications.
Goals of medical treatment are to resolve reflux esophagitis and minimize development of aspiration pneumonia. 2, 5, 6, 13 Complications such as aspiration pneumonia and esophageal stricture were rare in our study indicating that medical treatment plays an important role in decreasing morbidity associated with HH, GER, and reflux esophagitis, or that chronic intermittent reflux is rarely associated with stricture formation in cats, independent of medical treatment. Medical treatment for 30 days has been advocated before considering surgery in dogs with HH. 7, 12, 13 Delay of definitive correction, however, may lead to worsened reflux esophagitis, esophageal stricture, aspiration pneumonia, mucosal hemorrhage, or strangulation of incarcerated viscera. 2, 4, 5, 8, [12] [13] [14] 29, 30 Medical treatments recommended for HH include a combination of acid suppressants, prokinetics, and cytoprotective agents. Acid-suppressant medications such as H 2 RAs and PPIs decrease acidity of refluxed material and limit damage to esophageal mucosa. 6 A recent study showed that omeprazole q12h provided superior acid suppression in cats compared to famotidine q12h or placebo. 34 Prokinetic agents such as metoclopramide and cisapride increase the rate of gastric emptying, and cisapride is superior to metoclopramide for enhancing GEJ tone in the dog. 35 Cisapride and metoclopramide also stimulate esophageal peristalsis in the distal third of the feline esophagus where smooth muscle predominates. 35, 36 Cisapride is more potent than metoclopramide in treating delayed gastric emptying in small animals and may be preferred for decreasing GER in cats. 36 Cytoprotective agents such as sucralfate increase the resistance of the gastric and esophageal mucosa to acid injury. 2, 5, 6, 13 Because of low case numbers, we were unable to determine the superiority of any medication in cats with HH. However, we support the use of PPIs, cisapride, and sucralfate for medical treatment of HH and associated reflux esophagitis in cats. 6, 34, 36 Surgical management of HH in dogs and cats includes a combination of procedures, specifically phrenoplasty, esophagopexy, and gastropexy, resulting in reported success rates of 67%-100%. 3, 9 Combination procedures increase pressure at the GEJ and reinforce the anti-reflux barrier, and gastropexy has been recommended in conjunction with reduction of HH to enhance barrier pressure. 2, 7, 11, 37 Although only a short-term effect on barrier pressure has been demonstrated with gastropexy, even transient increases in barrier pressure may provide long-term benefit by decreasing GER-and esophagitis-associated inflammation, and 4 of 4 (100%) dogs in 1 study showed no signs of HH recurrence 18-24 months after phrenoplasty, esophagopexy, and left-sided gastropexy. 2, 37 All cats treated surgically in our study had some type of gastropexy performed, either as a solitary procedure or in combination with phrenoplasty or esophagopexy. Small sample size precluded determination of differences in overall survival or incidence of complications attributable to type of surgical procedure.
Our study had some limitations. The multi-institutional nature of the study contributed to variations in evaluation and treatment, and techniques were not standardized among cases. Data generated by this retrospective study reflected the quality of information available in medical records, and not all records were complete. Direct comparison among cases from different institutions was difficult because of variation in reference intervals, imaging protocols, surgical technique, and treatment plans. Cats with lower body weights and more severe signs may have been more likely to be selected for surgery or have clinically relevant comorbidities. The presence of major comorbidities in many cats may have created a bias toward selection of surgical treatment, because many of these cats had concurrent airway and other diseases and had additional abdominal procedures performed.
Because of the low number of cases overall and especially of cases treated medically without surgery, findings must be interpreted with caution because sample sizes were too small to use sample medians as estimates of treatment population medians. Post-discharge survival data were available only for 20 of 31 (64.5%) cats, and the majority (16/20) of these cats were treated surgically. Follow-up also was limited, because owners could not always be contacted or could not recall specific details.
Surgery has been recommended in dogs and cats with type I HH when severe esophageal ulceration or strictures are present and when the hernia is large or fixed in position. 2, 3, 15, 30 However, given the predominance of clinically relevant comorbidities and lower weights in cats treated surgically, our findings suggest that the choice of medical or surgical treatment should be dictated by severity of herniation,
